MBP is not a done deal, but it did passed phase 2b with flying...

MBP is not a done deal, but it did passed phase 2b with flying colours. Each successful trial reduces the risk of failure.

There is a massive market for weight reduction drugs, possibly the largest market in the developed world. A successful phase 3 trial could see the MBP drug become one of the most widely used drugs ever. Given this, and the problems associated with current drugs, it would be stupid for the majors to ignore MBP's potential.

The next push in sp will come from :

The US listing, which will see more interest in MBP given that the US investors are more used to investing in drug companies than Australian investors. It would be interesting to see how much of the current buying at such low prices is from US investors.

Increased reporting from Australian brokers and updates to older reports. In particular highlighting that the risk of MBP failure has fallen due to phase 2b success.

A deal for phase 3 support from a major drug company. This would include upfront cash payments and give some indication of the value of th drug.

If I was a major drug company I would be buying up shares in mbp at the moment.

G